DST Capital LLC - Dec 7, 2022 Form 4 Insider Report for Biostage, Inc. (BSTG)

Role
10%+ Owner
Signature
/s/ Chad Porter, Attorney-in-Fact
Stock symbol
BSTG
Transactions as of
Dec 7, 2022
Transactions value $
$4
Form type
4
Date filed
12/9/2022, 04:21 PM
Previous filing
May 19, 2022
Next filing
Apr 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSTG Common Stock Exercise of in-the-money or at-the-money derivative security $14K +7K +0.19% $2.00 3.67M Dec 7, 2022 Direct
transaction BSTG Common Stock Sale -$14K -1.95K -0.05% $7.17 3.66M Dec 7, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSTG Warrants (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -7K -100% $0.00* 0 Dec 7, 2022 Common Stock 7K $2.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 7, 2022, the Reporting Person exercised a warrant to purchase 7,000 shares of common stock for $2 per share. The Reporting Person paid the exercise price on a cashless basis, resulting in Biostage's withholding of 1,952 shares to pay the exercise price based on the daily VWAP of $7.1706, and issuing the remaining 5,048 shares of common stock.